Ankylosing Spondylitis
Conditions
Interventions
Group 1:moxibustion intervenion+conventional intervenion (From 17:00 to 19:00)
Group 2:Conventional intervention (NSAIDs, DMARDs, Biological Agents)
Group 3:moxibustion intervenion+conventional intervenion (Not from 17:00 to 19:00)
Sponsors
The Affiliated Changzhou 2nd People's Hospital of Nanjing Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Aged between 18 and 65 years; 2. Fulfilling the 1984 modified New York criteria (mNY) for AS; 3. Disease lasting for at least 6 months; 4. Nonsteroidal anti-inflammatory drugs (NSAID) will be on stable doses for at least 4 weeks; 5. The disease-modifying anti-rheumatic drugs (methotrexate, sulfasalazine) or anti-tumor necrosis factor (TNF) agents (infliximab, etanercept, adalimumab,etc.) will be on stable dosages for at least 3 months; 6. Able to speak and read Chinese; 7. Sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Other rheumatic diseases (rheumatoid arthritis, Sjogren syndrome, systemic lupus erythematosus, fibromyalgia,etc.) 2. History of heart failure, malignancies, uncontrolled hypertension, chronic obstructive pulmonary disease, diabetes mellitus requiring insulin injection, lymphoma, life-threatening neurological and gastrointestinal disorders, haemorrhagic disorders; 3. An active infectious disease, including tuberculosis; 4. A diagnosis of mental disorder; 5. Pregnant and lactating women; 6. Previous poor compliance; 7. Alcohol or drug addiction; Not suitable for moxibustion: TCM pattern differentiation of Heat Bi, moxibustion syncope, unwilling to be treated with moxibustion, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| BASDAI;BASFI;BASMI;ASQoL; | — |
Secondary
| Measure | Time frame |
|---|---|
| ESR/CRP;ASAS20/40; | — |
Countries
China
Contacts
Public ContactSun Zhi-Qin
The Affiliated Changzhou 2nd People's Hospital of Nanjing Medical University
Outcome results
None listed